- Home
- CLW vs NPCE Comparison
CLW vs NPCE Comparison
Compare CLW & NPCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CLW | NPCE |
|---|---|---|
| Founded | 2005 | 1997 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Paper | Medical Specialities |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 293.0M | 328.8M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | CLW | NPCE |
|---|---|---|
| Price | $17.96 | $16.36 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 7 |
| Target Price | ★ $30.00 | $17.00 |
| AVG Volume (30 Days) | 172.4K | ★ 246.6K |
| Earning Date | 10-28-2025 | 11-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 875.72 | N/A |
| EPS | ★ 8.63 | N/A |
| Revenue | ★ $1,556,100,000.00 | $94,864,000.00 |
| Revenue This Year | $13.91 | $24.82 |
| Revenue Next Year | N/A | $1.28 |
| P/E Ratio | $2.03 | ★ N/A |
| Revenue Growth | 23.00 | ★ 24.08 |
| 52 Week Low | $16.44 | $7.56 |
| 52 Week High | $33.57 | $18.98 |
Technical Indicators
Market Signals| Indicator | CLW | NPCE |
|---|---|---|
| Relative Strength Index (RSI) | 47.73 | 65.74 |
| Support Level | $17.39 | $15.61 |
| Resistance Level | $18.25 | $16.91 |
| Average True Range (ATR) | 0.72 | 0.95 |
| MACD | 0.11 | 0.09 |
| Stochastic Oscillator | 61.87 | 79.41 |
Price Performance
Historical ComparisonAbout CLW Clearwater Paper Corporation
Clearwater Paper Corp is engaged in the manufacturing and supplier of Solid Bleached Sulfate (SBS) paperboard packaging products. The company products includes: SBS paperboard which is a premium paperboard grade that is frequently used to produce folding cartons, food service, commercial printing items. It generates maximum revenue from Pulp and Paperboard segment. Company operate in United States and have globalized access too. Geographically, it derives maximum revenue from the United States.
About NPCE Neuropace Inc.
NeuroPace Inc is a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy by reducing or eliminating the occurrence of debilitating seizures. It derives substantially all of its revenue from the sales of RNS Systems to hospital facilities (typically Level 4 CECs) that implant RNS Systems.